Formulation and validation of a baseline prognostic score for osteosarcoma treated uniformly with a non-high dose methotrexate-based protocol from a low middle income healthcare setting: a single centre analysis of 594 patients

INTRODUCTION: The outcomes of osteosarcoma in low middle income countries (LMICs) are different due to patients presenting in advanced stages, resource constraints and the use of non-high-dose-methotrexate (HDMTX)-based regimens. This study derived and validated a prognostic score for osteosarcoma t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganguly, Shuvadeep, Sasi, Archana, Khan, Shah Alam, Kumar, Venkatesan Sampath, Kapoor, Love, Sharma, Mehar Chand, Mridha, Asit, Barwad, Adarsh, Thulkar, Sanjay, Pushpam, Deepam, Bakhshi, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175811/
https://www.ncbi.nlm.nih.gov/pubmed/37188186
http://dx.doi.org/10.3389/fonc.2023.1148480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175811/
https://www.ncbi.nlm.nih.gov/pubmed/37188186
http://dx.doi.org/10.3389/fonc.2023.1148480

Ejemplares similares